Article analyzes the European Medicines Agency’s review of CAR T therapy Axicabtagene Ciloleucel for treatment of relapsed DLBCL.
Home / Resource Library / EMA Review of Axicabtagene Ciloleucel (Yescarta) for the Treatment of Diffuse Large B-Cell Lymphoma